Similar articles

• Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

  Byers T, Trujillo S, Hines L. Byers T, et al. J Natl Cancer Inst. 2008 Apr 16;100(8):596. doi: 10.1093/jnci/djn078. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398102 No abstract available.
• Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

  Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L. Caan B, et al. J Natl Cancer Inst. 2008 Apr 16;100(8):597-8; author reply 599. doi: 10.1093/jnci/djn079. Epub 2008 Apr 8. J Natl Cancer Inst. 2008. PMID: 18398101 No abstract available.
• Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

  Glass AG, Lacey JV Jr, Carreon JD, Hoover RN. Glass AG, et al. J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. doi: 10.1093/jnci/djm059. Epub 2007 Jul 24. J Natl Cancer Inst. 2007. PMID: 17652280
• The Million Women Study and breast cancer.

  Speroff L. Speroff L. Maturitas. 2003 Sep 25;46(1):1-6. doi: 10.1016/j.maturitas.2003.08.001. Maturitas. 2003. PMID: 12963165 Review. No abstract available.
• Is there a role for hormone replacement therapy after breast cancer?

  Kwan K, Ward C, Marsden J. Kwan K, et al. J Br Menopause Soc. 2005 Dec;11(4):140-4. doi: 10.1258/136218005775544273. J Br Menopause Soc. 2005. PMID: 16354457 Review.